nodes	percent_of_prediction	percent_of_DWPC	metapath
Propranolol—CYP1A2—Pentoxifylline—systemic scleroderma	0.0912	0.141	CbGbCtD
Propranolol—CYP1A2—Leflunomide—systemic scleroderma	0.087	0.135	CbGbCtD
Propranolol—ABCB1—Lisinopril—systemic scleroderma	0.0798	0.123	CbGbCtD
Propranolol—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0722	0.112	CbGbCtD
Propranolol—ABCB1—Captopril—systemic scleroderma	0.0597	0.0923	CbGbCtD
Propranolol—CYP2D6—Captopril—systemic scleroderma	0.0563	0.087	CbGbCtD
Propranolol—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.047	0.0727	CbGbCtD
Propranolol—CYP2C19—Prednisone—systemic scleroderma	0.0466	0.072	CbGbCtD
Propranolol—ABCB1—Prednisone—systemic scleroderma	0.0376	0.0581	CbGbCtD
Propranolol—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0282	0.0435	CbGbCtD
Propranolol—CYP3A4—Prednisone—systemic scleroderma	0.0225	0.0348	CbGbCtD
Propranolol—ABCB1—Methotrexate—systemic scleroderma	0.0189	0.0291	CbGbCtD
Propranolol—Purpura—Prednisone—systemic scleroderma	0.000717	0.00203	CcSEcCtD
Propranolol—Agitation—Mycophenolic acid—systemic scleroderma	0.000715	0.00203	CcSEcCtD
Propranolol—Cough—Leflunomide—systemic scleroderma	0.000712	0.00202	CcSEcCtD
Propranolol—Alopecia—Lisinopril—systemic scleroderma	0.000711	0.00201	CcSEcCtD
Propranolol—Dyspepsia—Captopril—systemic scleroderma	0.000711	0.00201	CcSEcCtD
Propranolol—Mental disorder—Lisinopril—systemic scleroderma	0.000705	0.002	CcSEcCtD
Propranolol—Lethargy—Prednisone—systemic scleroderma	0.000705	0.002	CcSEcCtD
Propranolol—Dizziness—Pentoxifylline—systemic scleroderma	0.000705	0.002	CcSEcCtD
Propranolol—Decreased appetite—Captopril—systemic scleroderma	0.000702	0.00199	CcSEcCtD
Propranolol—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.000702	0.00199	CcSEcCtD
Propranolol—Erythema—Lisinopril—systemic scleroderma	0.000701	0.00198	CcSEcCtD
Propranolol—Infection—Azathioprine—systemic scleroderma	0.0007	0.00198	CcSEcCtD
Propranolol—Pharyngitis—Mycophenolate mofetil—systemic scleroderma	0.0007	0.00198	CcSEcCtD
Propranolol—Vertigo—Mycophenolic acid—systemic scleroderma	0.000699	0.00198	CcSEcCtD
Propranolol—Fatigue—Captopril—systemic scleroderma	0.000696	0.00197	CcSEcCtD
Propranolol—Constipation—Captopril—systemic scleroderma	0.000691	0.00196	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00069	0.00195	CcSEcCtD
Propranolol—Skin disorder—Azathioprine—systemic scleroderma	0.000685	0.00194	CcSEcCtD
Propranolol—Affect lability—Prednisone—systemic scleroderma	0.00068	0.00193	CcSEcCtD
Propranolol—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.00068	0.00193	CcSEcCtD
Propranolol—Cough—Mycophenolic acid—systemic scleroderma	0.000679	0.00192	CcSEcCtD
Propranolol—Vomiting—Pentoxifylline—systemic scleroderma	0.000678	0.00192	CcSEcCtD
Propranolol—Convulsion—Mycophenolic acid—systemic scleroderma	0.000674	0.00191	CcSEcCtD
Propranolol—Rash—Pentoxifylline—systemic scleroderma	0.000672	0.0019	CcSEcCtD
Propranolol—Dermatitis—Pentoxifylline—systemic scleroderma	0.000671	0.0019	CcSEcCtD
Propranolol—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000666	0.00189	CcSEcCtD
Propranolol—Infection—Leflunomide—systemic scleroderma	0.000661	0.00187	CcSEcCtD
Propranolol—Gastrointestinal pain—Captopril—systemic scleroderma	0.00066	0.00187	CcSEcCtD
Propranolol—Asthenia—Mometasone—systemic scleroderma	0.00066	0.00187	CcSEcCtD
Propranolol—Irritability—Prednisone—systemic scleroderma	0.00066	0.00187	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000658	0.00186	CcSEcCtD
Propranolol—Cardiac arrest—Prednisone—systemic scleroderma	0.000657	0.00186	CcSEcCtD
Propranolol—Mood swings—Prednisone—systemic scleroderma	0.000655	0.00185	CcSEcCtD
Propranolol—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.000655	0.00185	CcSEcCtD
Propranolol—Nervous system disorder—Leflunomide—systemic scleroderma	0.000653	0.00185	CcSEcCtD
Propranolol—Skin disorder—Leflunomide—systemic scleroderma	0.000647	0.00183	CcSEcCtD
Propranolol—Abdominal pain—Captopril—systemic scleroderma	0.000638	0.00181	CcSEcCtD
Propranolol—Body temperature increased—Captopril—systemic scleroderma	0.000638	0.00181	CcSEcCtD
Propranolol—Nausea—Pentoxifylline—systemic scleroderma	0.000633	0.00179	CcSEcCtD
Propranolol—Infection—Mycophenolic acid—systemic scleroderma	0.000631	0.00179	CcSEcCtD
Propranolol—Vertigo—Lisinopril—systemic scleroderma	0.00063	0.00178	CcSEcCtD
Propranolol—Diarrhoea—Mometasone—systemic scleroderma	0.000629	0.00178	CcSEcCtD
Propranolol—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000623	0.00177	CcSEcCtD
Propranolol—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000623	0.00176	CcSEcCtD
Propranolol—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000618	0.00175	CcSEcCtD
Propranolol—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000617	0.00175	CcSEcCtD
Propranolol—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.000612	0.00173	CcSEcCtD
Propranolol—Cough—Lisinopril—systemic scleroderma	0.000612	0.00173	CcSEcCtD
Propranolol—Visual disturbance—Methotrexate—systemic scleroderma	0.00061	0.00173	CcSEcCtD
Propranolol—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000609	0.00172	CcSEcCtD
Propranolol—Insomnia—Leflunomide—systemic scleroderma	0.000602	0.00171	CcSEcCtD
Propranolol—Paraesthesia—Leflunomide—systemic scleroderma	0.000598	0.00169	CcSEcCtD
Propranolol—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.000597	0.00169	CcSEcCtD
Propranolol—Dyspnoea—Leflunomide—systemic scleroderma	0.000593	0.00168	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000593	0.00168	CcSEcCtD
Propranolol—Lethargy—Methotrexate—systemic scleroderma	0.000589	0.00167	CcSEcCtD
Propranolol—Dyspepsia—Leflunomide—systemic scleroderma	0.000586	0.00166	CcSEcCtD
Propranolol—Vomiting—Mometasone—systemic scleroderma	0.000585	0.00166	CcSEcCtD
Propranolol—Rash—Mometasone—systemic scleroderma	0.00058	0.00164	CcSEcCtD
Propranolol—Asthenia—Captopril—systemic scleroderma	0.000579	0.00164	CcSEcCtD
Propranolol—Dermatitis—Mometasone—systemic scleroderma	0.000579	0.00164	CcSEcCtD
Propranolol—Decreased appetite—Leflunomide—systemic scleroderma	0.000579	0.00164	CcSEcCtD
Propranolol—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000576	0.00163	CcSEcCtD
Propranolol—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000575	0.00163	CcSEcCtD
Propranolol—Insomnia—Mycophenolic acid—systemic scleroderma	0.000574	0.00163	CcSEcCtD
Propranolol—Fatigue—Leflunomide—systemic scleroderma	0.000574	0.00163	CcSEcCtD
Propranolol—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000572	0.00162	CcSEcCtD
Propranolol—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00057	0.00161	CcSEcCtD
Propranolol—Pain—Leflunomide—systemic scleroderma	0.000569	0.00161	CcSEcCtD
Propranolol—Constipation—Leflunomide—systemic scleroderma	0.000569	0.00161	CcSEcCtD
Propranolol—Infection—Lisinopril—systemic scleroderma	0.000568	0.00161	CcSEcCtD
Propranolol—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000566	0.0016	CcSEcCtD
Propranolol—Somnolence—Mycophenolic acid—systemic scleroderma	0.000565	0.0016	CcSEcCtD
Propranolol—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000564	0.0016	CcSEcCtD
Propranolol—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000559	0.00158	CcSEcCtD
Propranolol—Neutropenia—Prednisone—systemic scleroderma	0.000559	0.00158	CcSEcCtD
Propranolol—Abdominal pain—Azathioprine—systemic scleroderma	0.000557	0.00158	CcSEcCtD
Propranolol—Body temperature increased—Azathioprine—systemic scleroderma	0.000557	0.00158	CcSEcCtD
Propranolol—Skin disorder—Lisinopril—systemic scleroderma	0.000556	0.00157	CcSEcCtD
Propranolol—Diarrhoea—Captopril—systemic scleroderma	0.000553	0.00157	CcSEcCtD
Propranolol—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000552	0.00156	CcSEcCtD
Propranolol—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000552	0.00156	CcSEcCtD
Propranolol—Irritability—Methotrexate—systemic scleroderma	0.000551	0.00156	CcSEcCtD
Propranolol—Erectile dysfunction—Prednisone—systemic scleroderma	0.00055	0.00156	CcSEcCtD
Propranolol—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000548	0.00155	CcSEcCtD
Propranolol—Fatigue—Mycophenolic acid—systemic scleroderma	0.000547	0.00155	CcSEcCtD
Propranolol—Mood swings—Methotrexate—systemic scleroderma	0.000547	0.00155	CcSEcCtD
Propranolol—Nausea—Mometasone—systemic scleroderma	0.000546	0.00155	CcSEcCtD
Propranolol—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000544	0.00154	CcSEcCtD
Propranolol—Pain—Mycophenolic acid—systemic scleroderma	0.000543	0.00154	CcSEcCtD
Propranolol—Constipation—Mycophenolic acid—systemic scleroderma	0.000543	0.00154	CcSEcCtD
Propranolol—Cough—Mycophenolate mofetil—systemic scleroderma	0.000536	0.00152	CcSEcCtD
Propranolol—Dizziness—Captopril—systemic scleroderma	0.000534	0.00151	CcSEcCtD
Propranolol—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000532	0.00151	CcSEcCtD
Propranolol—Depression—Prednisone—systemic scleroderma	0.000531	0.0015	CcSEcCtD
Propranolol—Urticaria—Leflunomide—systemic scleroderma	0.000529	0.0015	CcSEcCtD
Propranolol—Abdominal pain—Leflunomide—systemic scleroderma	0.000526	0.00149	CcSEcCtD
Propranolol—Body temperature increased—Leflunomide—systemic scleroderma	0.000526	0.00149	CcSEcCtD
Propranolol—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.00052	0.00147	CcSEcCtD
Propranolol—Hypersensitivity—Azathioprine—systemic scleroderma	0.000519	0.00147	CcSEcCtD
Propranolol—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000519	0.00147	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000519	0.00147	CcSEcCtD
Propranolol—Insomnia—Lisinopril—systemic scleroderma	0.000517	0.00147	CcSEcCtD
Propranolol—Paraesthesia—Lisinopril—systemic scleroderma	0.000514	0.00145	CcSEcCtD
Propranolol—Vomiting—Captopril—systemic scleroderma	0.000514	0.00145	CcSEcCtD
Propranolol—Dyspnoea—Lisinopril—systemic scleroderma	0.00051	0.00144	CcSEcCtD
Propranolol—Rash—Captopril—systemic scleroderma	0.000509	0.00144	CcSEcCtD
Propranolol—Dermatitis—Captopril—systemic scleroderma	0.000509	0.00144	CcSEcCtD
Propranolol—Somnolence—Lisinopril—systemic scleroderma	0.000508	0.00144	CcSEcCtD
Propranolol—Dyspepsia—Lisinopril—systemic scleroderma	0.000503	0.00143	CcSEcCtD
Propranolol—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000502	0.00142	CcSEcCtD
Propranolol—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000502	0.00142	CcSEcCtD
Propranolol—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000501	0.00142	CcSEcCtD
Propranolol—Infection—Mycophenolate mofetil—systemic scleroderma	0.000498	0.00141	CcSEcCtD
Propranolol—Decreased appetite—Lisinopril—systemic scleroderma	0.000497	0.00141	CcSEcCtD
Propranolol—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000494	0.0014	CcSEcCtD
Propranolol—Fatigue—Lisinopril—systemic scleroderma	0.000493	0.0014	CcSEcCtD
Propranolol—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000491	0.00139	CcSEcCtD
Propranolol—Hypersensitivity—Leflunomide—systemic scleroderma	0.00049	0.00139	CcSEcCtD
Propranolol—Pain—Lisinopril—systemic scleroderma	0.000489	0.00139	CcSEcCtD
Propranolol—Constipation—Lisinopril—systemic scleroderma	0.000489	0.00139	CcSEcCtD
Propranolol—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000487	0.00138	CcSEcCtD
Propranolol—Bradycardia—Prednisone—systemic scleroderma	0.000487	0.00138	CcSEcCtD
Propranolol—Diarrhoea—Azathioprine—systemic scleroderma	0.000482	0.00137	CcSEcCtD
Propranolol—Nausea—Captopril—systemic scleroderma	0.00048	0.00136	CcSEcCtD
Propranolol—Asthenia—Leflunomide—systemic scleroderma	0.000478	0.00135	CcSEcCtD
Propranolol—Hallucination—Prednisone—systemic scleroderma	0.000476	0.00135	CcSEcCtD
Propranolol—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000468	0.00132	CcSEcCtD
Propranolol—Neutropenia—Methotrexate—systemic scleroderma	0.000467	0.00132	CcSEcCtD
Propranolol—Dizziness—Azathioprine—systemic scleroderma	0.000466	0.00132	CcSEcCtD
Propranolol—Erectile dysfunction—Methotrexate—systemic scleroderma	0.00046	0.0013	CcSEcCtD
Propranolol—Asthenia—Mycophenolic acid—systemic scleroderma	0.000456	0.00129	CcSEcCtD
Propranolol—Diarrhoea—Leflunomide—systemic scleroderma	0.000455	0.00129	CcSEcCtD
Propranolol—Urticaria—Lisinopril—systemic scleroderma	0.000454	0.00129	CcSEcCtD
Propranolol—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000453	0.00128	CcSEcCtD
Propranolol—Abdominal pain—Lisinopril—systemic scleroderma	0.000452	0.00128	CcSEcCtD
Propranolol—Body temperature increased—Lisinopril—systemic scleroderma	0.000452	0.00128	CcSEcCtD
Propranolol—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00045	0.00127	CcSEcCtD
Propranolol—Vomiting—Azathioprine—systemic scleroderma	0.000448	0.00127	CcSEcCtD
Propranolol—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000447	0.00127	CcSEcCtD
Propranolol—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000446	0.00126	CcSEcCtD
Propranolol—Infestation—Methotrexate—systemic scleroderma	0.000445	0.00126	CcSEcCtD
Propranolol—Infestation NOS—Methotrexate—systemic scleroderma	0.000445	0.00126	CcSEcCtD
Propranolol—Rash—Azathioprine—systemic scleroderma	0.000444	0.00126	CcSEcCtD
Propranolol—Dermatitis—Azathioprine—systemic scleroderma	0.000444	0.00126	CcSEcCtD
Propranolol—Depression—Methotrexate—systemic scleroderma	0.000444	0.00126	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000441	0.00125	CcSEcCtD
Propranolol—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000441	0.00125	CcSEcCtD
Propranolol—Dizziness—Leflunomide—systemic scleroderma	0.00044	0.00125	CcSEcCtD
Propranolol—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000436	0.00123	CcSEcCtD
Propranolol—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000434	0.00123	CcSEcCtD
Propranolol—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000433	0.00123	CcSEcCtD
Propranolol—Pain—Mycophenolate mofetil—systemic scleroderma	0.000429	0.00121	CcSEcCtD
Propranolol—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000429	0.00121	CcSEcCtD
Propranolol—Vomiting—Leflunomide—systemic scleroderma	0.000423	0.0012	CcSEcCtD
Propranolol—Alopecia—Prednisone—systemic scleroderma	0.000423	0.0012	CcSEcCtD
Propranolol—Hypersensitivity—Lisinopril—systemic scleroderma	0.000421	0.00119	CcSEcCtD
Propranolol—Dizziness—Mycophenolic acid—systemic scleroderma	0.00042	0.00119	CcSEcCtD
Propranolol—Rash—Leflunomide—systemic scleroderma	0.00042	0.00119	CcSEcCtD
Propranolol—Dermatitis—Leflunomide—systemic scleroderma	0.000419	0.00119	CcSEcCtD
Propranolol—Mental disorder—Prednisone—systemic scleroderma	0.000419	0.00119	CcSEcCtD
Propranolol—Nausea—Azathioprine—systemic scleroderma	0.000419	0.00119	CcSEcCtD
Propranolol—Erythema—Prednisone—systemic scleroderma	0.000416	0.00118	CcSEcCtD
Propranolol—Agranulocytosis—Methotrexate—systemic scleroderma	0.000415	0.00118	CcSEcCtD
Propranolol—Asthenia—Lisinopril—systemic scleroderma	0.00041	0.00116	CcSEcCtD
Propranolol—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00041	0.00116	CcSEcCtD
Propranolol—Vomiting—Mycophenolic acid—systemic scleroderma	0.000404	0.00114	CcSEcCtD
Propranolol—Rash—Mycophenolic acid—systemic scleroderma	0.0004	0.00113	CcSEcCtD
Propranolol—Dermatitis—Mycophenolic acid—systemic scleroderma	0.0004	0.00113	CcSEcCtD
Propranolol—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000398	0.00113	CcSEcCtD
Propranolol—Pharyngitis—Methotrexate—systemic scleroderma	0.000397	0.00112	CcSEcCtD
Propranolol—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000396	0.00112	CcSEcCtD
Propranolol—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000396	0.00112	CcSEcCtD
Propranolol—Nausea—Leflunomide—systemic scleroderma	0.000395	0.00112	CcSEcCtD
Propranolol—Diarrhoea—Lisinopril—systemic scleroderma	0.000391	0.00111	CcSEcCtD
Propranolol—Visual impairment—Methotrexate—systemic scleroderma	0.000385	0.00109	CcSEcCtD
Propranolol—Agitation—Prednisone—systemic scleroderma	0.000383	0.00108	CcSEcCtD
Propranolol—Dizziness—Lisinopril—systemic scleroderma	0.000378	0.00107	CcSEcCtD
Propranolol—Erythema multiforme—Methotrexate—systemic scleroderma	0.000378	0.00107	CcSEcCtD
Propranolol—Nausea—Mycophenolic acid—systemic scleroderma	0.000377	0.00107	CcSEcCtD
Propranolol—Vertigo—Prednisone—systemic scleroderma	0.000374	0.00106	CcSEcCtD
Propranolol—Cardiac disorder—Methotrexate—systemic scleroderma	0.000371	0.00105	CcSEcCtD
Propranolol—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000369	0.00105	CcSEcCtD
Propranolol—Vomiting—Lisinopril—systemic scleroderma	0.000364	0.00103	CcSEcCtD
Propranolol—Rash—Lisinopril—systemic scleroderma	0.000361	0.00102	CcSEcCtD
Propranolol—Convulsion—Prednisone—systemic scleroderma	0.000361	0.00102	CcSEcCtD
Propranolol—Dermatitis—Lisinopril—systemic scleroderma	0.00036	0.00102	CcSEcCtD
Propranolol—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00036	0.00102	CcSEcCtD
Propranolol—Alopecia—Methotrexate—systemic scleroderma	0.000353	0.001	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000352	0.000997	CcSEcCtD
Propranolol—Mental disorder—Methotrexate—systemic scleroderma	0.00035	0.000991	CcSEcCtD
Propranolol—Erythema—Methotrexate—systemic scleroderma	0.000348	0.000985	CcSEcCtD
Propranolol—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000343	0.000971	CcSEcCtD
Propranolol—Nausea—Lisinopril—systemic scleroderma	0.00034	0.000962	CcSEcCtD
Propranolol—Anaphylactic shock—Prednisone—systemic scleroderma	0.00034	0.000962	CcSEcCtD
Propranolol—Infection—Prednisone—systemic scleroderma	0.000337	0.000956	CcSEcCtD
Propranolol—Nervous system disorder—Prednisone—systemic scleroderma	0.000333	0.000943	CcSEcCtD
Propranolol—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000331	0.000939	CcSEcCtD
Propranolol—Skin disorder—Prednisone—systemic scleroderma	0.00033	0.000934	CcSEcCtD
Propranolol—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000319	0.000902	CcSEcCtD
Propranolol—Rash—Mycophenolate mofetil—systemic scleroderma	0.000316	0.000895	CcSEcCtD
Propranolol—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000316	0.000894	CcSEcCtD
Propranolol—Vertigo—Methotrexate—systemic scleroderma	0.000313	0.000885	CcSEcCtD
Propranolol—Insomnia—Prednisone—systemic scleroderma	0.000307	0.00087	CcSEcCtD
Propranolol—Paraesthesia—Prednisone—systemic scleroderma	0.000305	0.000864	CcSEcCtD
Propranolol—Cough—Methotrexate—systemic scleroderma	0.000304	0.00086	CcSEcCtD
Propranolol—Convulsion—Methotrexate—systemic scleroderma	0.000301	0.000854	CcSEcCtD
Propranolol—Dyspepsia—Prednisone—systemic scleroderma	0.000299	0.000847	CcSEcCtD
Propranolol—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000298	0.000843	CcSEcCtD
Propranolol—Decreased appetite—Prednisone—systemic scleroderma	0.000295	0.000836	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000294	0.000833	CcSEcCtD
Propranolol—Fatigue—Prednisone—systemic scleroderma	0.000293	0.000829	CcSEcCtD
Propranolol—Constipation—Prednisone—systemic scleroderma	0.00029	0.000823	CcSEcCtD
Propranolol—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000284	0.000804	CcSEcCtD
Propranolol—Infection—Methotrexate—systemic scleroderma	0.000282	0.000799	CcSEcCtD
Propranolol—Nervous system disorder—Methotrexate—systemic scleroderma	0.000278	0.000788	CcSEcCtD
Propranolol—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000278	0.000787	CcSEcCtD
Propranolol—Skin disorder—Methotrexate—systemic scleroderma	0.000276	0.000781	CcSEcCtD
Propranolol—Urticaria—Prednisone—systemic scleroderma	0.00027	0.000764	CcSEcCtD
Propranolol—Abdominal pain—Prednisone—systemic scleroderma	0.000269	0.000761	CcSEcCtD
Propranolol—Body temperature increased—Prednisone—systemic scleroderma	0.000269	0.000761	CcSEcCtD
Propranolol—Insomnia—Methotrexate—systemic scleroderma	0.000257	0.000727	CcSEcCtD
Propranolol—Paraesthesia—Methotrexate—systemic scleroderma	0.000255	0.000722	CcSEcCtD
Propranolol—Dyspnoea—Methotrexate—systemic scleroderma	0.000253	0.000717	CcSEcCtD
Propranolol—Somnolence—Methotrexate—systemic scleroderma	0.000252	0.000715	CcSEcCtD
Propranolol—Hypersensitivity—Prednisone—systemic scleroderma	0.00025	0.000709	CcSEcCtD
Propranolol—Dyspepsia—Methotrexate—systemic scleroderma	0.00025	0.000708	CcSEcCtD
Propranolol—Decreased appetite—Methotrexate—systemic scleroderma	0.000247	0.000699	CcSEcCtD
Propranolol—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000245	0.000694	CcSEcCtD
Propranolol—Fatigue—Methotrexate—systemic scleroderma	0.000245	0.000693	CcSEcCtD
Propranolol—Asthenia—Prednisone—systemic scleroderma	0.000244	0.00069	CcSEcCtD
Propranolol—Pain—Methotrexate—systemic scleroderma	0.000243	0.000688	CcSEcCtD
Propranolol—Diarrhoea—Prednisone—systemic scleroderma	0.000232	0.000658	CcSEcCtD
Propranolol—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000232	0.000657	CcSEcCtD
Propranolol—Urticaria—Methotrexate—systemic scleroderma	0.000226	0.000639	CcSEcCtD
Propranolol—Dizziness—Prednisone—systemic scleroderma	0.000225	0.000636	CcSEcCtD
Propranolol—Abdominal pain—Methotrexate—systemic scleroderma	0.000224	0.000636	CcSEcCtD
Propranolol—Body temperature increased—Methotrexate—systemic scleroderma	0.000224	0.000636	CcSEcCtD
Propranolol—Vomiting—Prednisone—systemic scleroderma	0.000216	0.000612	CcSEcCtD
Propranolol—Rash—Prednisone—systemic scleroderma	0.000214	0.000607	CcSEcCtD
Propranolol—Dermatitis—Prednisone—systemic scleroderma	0.000214	0.000606	CcSEcCtD
Propranolol—Hypersensitivity—Methotrexate—systemic scleroderma	0.000209	0.000592	CcSEcCtD
Propranolol—Asthenia—Methotrexate—systemic scleroderma	0.000204	0.000577	CcSEcCtD
Propranolol—Nausea—Prednisone—systemic scleroderma	0.000202	0.000571	CcSEcCtD
Propranolol—Diarrhoea—Methotrexate—systemic scleroderma	0.000194	0.00055	CcSEcCtD
Propranolol—Dizziness—Methotrexate—systemic scleroderma	0.000188	0.000532	CcSEcCtD
Propranolol—Vomiting—Methotrexate—systemic scleroderma	0.000181	0.000511	CcSEcCtD
Propranolol—Rash—Methotrexate—systemic scleroderma	0.000179	0.000507	CcSEcCtD
Propranolol—Dermatitis—Methotrexate—systemic scleroderma	0.000179	0.000506	CcSEcCtD
Propranolol—Nausea—Methotrexate—systemic scleroderma	0.000169	0.000478	CcSEcCtD
